Koshinski Asset Management
GRCE

Koshinski Asset Management’s Grace Therapeutics GRCE Stock Holding History

Koshinski Asset Management’s Portfolio GRCE Stock Details GRCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-333
Closed -$2.44K – 2019
2022
Q1 		$2.44K Hold
333
– – ﹤0.01% 1936
2021
Q4 		$2.52K Buy
+333
New +$3K ﹤0.01% 1945

Other funds holding GRCE

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Koshinski Asset Management's GRCE Position: Q2 2022 in Review

Koshinski Asset Management sold out of Grace Therapeutics (GRCE) in Q2 2022, closing a stake of 333 shares — an estimated $2.44K sold.

Koshinski Asset Management first reported a position in GRCE in Q4 2021 and held it in 2 quarters. The position peaked at $2.52K in Q4 2021. 12 funds tracked by Wall St. Rank hold GRCE as of Q2 2022.

  • Koshinski Asset Management reported no remaining Grace Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 333 Grace Therapeutics shares in Q2 2022, an estimated $2.44K.
  • Koshinski Asset Management first reported a position in Grace Therapeutics in Q4 2021 and held it in 2 quarters.
  • Koshinski Asset Management's Grace Therapeutics position peaked at $2.52K in Q4 2021.
  • 12 funds tracked by Wall St. Rank held Grace Therapeutics as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.